Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.
出版信息
PLoS One. 2022 Mar 31;17(3):e0266498. doi: 10.1371/journal.pone.0266498. eCollection 2022.
Abstract
摘要
相似文献
1
Expression of Concern: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.关注声明：干扰素与利巴韦林联合治疗在多核糖体形成水平上协同抑制丙型肝炎病毒内部核糖体进入位点介导的翻译。
PLoS One. 2022 Mar 31;17(3):e0266498. doi: 10.1371/journal.pone.0266498. eCollection 2022.
2
Retraction: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.撤稿声明：干扰素与利巴韦林联合治疗在多核糖体形成水平上协同抑制丙型肝炎病毒内部核糖体进入位点介导的翻译。
PLoS One. 2024 Aug 5;19(8):e0308579. doi: 10.1371/journal.pone.0308579. eCollection 2024.
3
Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?真核起始因子 5B：利巴韦林抗丙型肝炎病毒作用的新靶点？
Med Hypotheses. 2012 Oct;79(4):471-3. doi: 10.1016/j.mehy.2012.06.026. Epub 2012 Jul 21.
4
Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.α、β、γ干扰素均在内质网核糖体进入位点介导的翻译水平上抑制丙型肝炎病毒复制。
Liver Int. 2005 Jun;25(3):580-94. doi: 10.1111/j.1478-3231.2005.01082.x.
5
The regulation of hepatitis C virus (HCV) internal ribosome-entry site-mediated translation by HCV replicons and nonstructural proteins.丙型肝炎病毒（HCV）复制子和非结构蛋白对丙型肝炎病毒（HCV）内部核糖体进入位点介导的翻译的调控。
J Gen Virol. 2003 Mar;84(Pt 3):535-543. doi: 10.1099/vir.0.18658-0.
6
Targeting hepatitis C virus translation: stopping HCV where it starts.靶向丙型肝炎病毒翻译：从源头阻止丙肝病毒
Curr Opin Investig Drugs. 2003 Feb;4(2):162-7.
7
Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.干扰素通过一条不依赖双链RNA激活蛋白激酶的途径特异性抑制丙型肝炎病毒内部核糖体进入位点的翻译。
J Infect Dis. 2002 Jul 15;186(2):155-63. doi: 10.1086/341467. Epub 2002 Jul 3.
8
Mutational Analysis of the Bovine Hepacivirus Internal Ribosome Entry Site.牛型肝炎病毒内部核糖体进入位点的突变分析。
J Virol. 2018 Jul 17;92(15). doi: 10.1128/JVI.01974-17. Print 2018 Aug 1.
9
Unlike for cellular mRNAs and other viral internal ribosome entry sites (IRESs), the eIF3 subunit e is not required for the translational activity of the HCV IRES.与细胞 mRNA 和其他病毒内部核糖体进入位点 (IRES) 不同，eIF3 亚基 e 不是 HCV IRES 翻译活性所必需的。
J Biol Chem. 2020 Feb 14;295(7):1843-1856. doi: 10.1074/jbc.RA119.009502. Epub 2020 Jan 12.
10
Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.运用功能基因组学方法鉴定真核生物翻译起始因子2Bγ亚基（eIF2Bγ）和真核生物翻译起始因子2γ亚基（eIF2γ）作为丙型肝炎病毒内部核糖体进入位点介导翻译的辅助因子。
Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8566-71. doi: 10.1073/pnas.97.15.8566.
引用本文的文献
1
Retraction: Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation.撤稿声明：干扰素与利巴韦林联合治疗在多核糖体形成水平上协同抑制丙型肝炎病毒内部核糖体进入位点介导的翻译。
PLoS One. 2024 Aug 5;19(8):e0308579. doi: 10.1371/journal.pone.0308579. eCollection 2024.
本文引用的文献
1
Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.干扰素和利巴韦林联合治疗通过多核糖体形成水平协同抑制 HCV 内部核糖体进入位点介导的翻译。
PLoS One. 2013 Aug 23;8(8):e72791. doi: 10.1371/journal.pone.0072791. eCollection 2013.
2
Alpha interferon inhibits translation mediated by the internal ribosome entry site of six different hepatitis C virus genotypes.α干扰素可抑制六种不同丙型肝炎病毒基因型的内部核糖体进入位点介导的翻译过程。
J Gen Virol. 2005 Nov;86(Pt 11):3047-3053. doi: 10.1099/vir.0.81132-0.
Zotero 插件